The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Imatinib Drugs Market Research Report 2025
Synopsis
Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
The global Imatinib Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Imatinib Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imatinib Drugs.
Report Scope
The Imatinib Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Imatinib Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imatinib Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Viatris
Novartis
Sanofi S.A.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Dr. Reddy's Laboratories
Cipla Inc.
Apotex Inc.
Segment by Type
Capsules
Tablets
Segment by Application
Hospitals
Drug Stores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Imatinib Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
The global Imatinib Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Imatinib Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imatinib Drugs.
Report Scope
The Imatinib Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Imatinib Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imatinib Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Viatris
Novartis
Sanofi S.A.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Dr. Reddy's Laboratories
Cipla Inc.
Apotex Inc.
Segment by Type
Capsules
Tablets
Segment by Application
Hospitals
Drug Stores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Imatinib Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Imatinib Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Capsules
1.2.3 Tablets
1.3 Market by Application
1.3.1 Global Imatinib Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Drug Stores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Imatinib Drugs Market Perspective (2019-2030)
2.2 Imatinib Drugs Growth Trends by Region
2.2.1 Global Imatinib Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Imatinib Drugs Historic Market Size by Region (2019-2024)
2.2.3 Imatinib Drugs Forecasted Market Size by Region (2025-2030)
2.3 Imatinib Drugs Market Dynamics
2.3.1 Imatinib Drugs Industry Trends
2.3.2 Imatinib Drugs Market Drivers
2.3.3 Imatinib Drugs Market Challenges
2.3.4 Imatinib Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Imatinib Drugs Players by Revenue
3.1.1 Global Top Imatinib Drugs Players by Revenue (2019-2024)
3.1.2 Global Imatinib Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Imatinib Drugs Revenue
3.4 Global Imatinib Drugs Market Concentration Ratio
3.4.1 Global Imatinib Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Imatinib Drugs Revenue in 2023
3.5 Imatinib Drugs Key Players Head office and Area Served
3.6 Key Players Imatinib Drugs Product Solution and Service
3.7 Date of Enter into Imatinib Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Imatinib Drugs Breakdown Data by Type
4.1 Global Imatinib Drugs Historic Market Size by Type (2019-2024)
4.2 Global Imatinib Drugs Forecasted Market Size by Type (2025-2030)
5 Imatinib Drugs Breakdown Data by Application
5.1 Global Imatinib Drugs Historic Market Size by Application (2019-2024)
5.2 Global Imatinib Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Imatinib Drugs Market Size (2019-2030)
6.2 North America Imatinib Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Imatinib Drugs Market Size by Country (2019-2024)
6.4 North America Imatinib Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Imatinib Drugs Market Size (2019-2030)
7.2 Europe Imatinib Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Imatinib Drugs Market Size by Country (2019-2024)
7.4 Europe Imatinib Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Imatinib Drugs Market Size (2019-2030)
8.2 Asia-Pacific Imatinib Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Imatinib Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Imatinib Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Imatinib Drugs Market Size (2019-2030)
9.2 Latin America Imatinib Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Imatinib Drugs Market Size by Country (2019-2024)
9.4 Latin America Imatinib Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Imatinib Drugs Market Size (2019-2030)
10.2 Middle East & Africa Imatinib Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Imatinib Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Imatinib Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Imatinib Drugs Introduction
11.1.4 Teva Revenue in Imatinib Drugs Business (2019-2024)
11.1.5 Teva Recent Development
11.2 Viatris
11.2.1 Viatris Company Detail
11.2.2 Viatris Business Overview
11.2.3 Viatris Imatinib Drugs Introduction
11.2.4 Viatris Revenue in Imatinib Drugs Business (2019-2024)
11.2.5 Viatris Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Imatinib Drugs Introduction
11.3.4 Novartis Revenue in Imatinib Drugs Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Sanofi S.A.
11.4.1 Sanofi S.A. Company Detail
11.4.2 Sanofi S.A. Business Overview
11.4.3 Sanofi S.A. Imatinib Drugs Introduction
11.4.4 Sanofi S.A. Revenue in Imatinib Drugs Business (2019-2024)
11.4.5 Sanofi S.A. Recent Development
11.5 Glenmark Pharmaceuticals Ltd.
11.5.1 Glenmark Pharmaceuticals Ltd. Company Detail
11.5.2 Glenmark Pharmaceuticals Ltd. Business Overview
11.5.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Introduction
11.5.4 Glenmark Pharmaceuticals Ltd. Revenue in Imatinib Drugs Business (2019-2024)
11.5.5 Glenmark Pharmaceuticals Ltd. Recent Development
11.6 Sun Pharmaceuticals
11.6.1 Sun Pharmaceuticals Company Detail
11.6.2 Sun Pharmaceuticals Business Overview
11.6.3 Sun Pharmaceuticals Imatinib Drugs Introduction
11.6.4 Sun Pharmaceuticals Revenue in Imatinib Drugs Business (2019-2024)
11.6.5 Sun Pharmaceuticals Recent Development
11.7 Dr. Reddy's Laboratories
11.7.1 Dr. Reddy's Laboratories Company Detail
11.7.2 Dr. Reddy's Laboratories Business Overview
11.7.3 Dr. Reddy's Laboratories Imatinib Drugs Introduction
11.7.4 Dr. Reddy's Laboratories Revenue in Imatinib Drugs Business (2019-2024)
11.7.5 Dr. Reddy's Laboratories Recent Development
11.8 Cipla Inc.
11.8.1 Cipla Inc. Company Detail
11.8.2 Cipla Inc. Business Overview
11.8.3 Cipla Inc. Imatinib Drugs Introduction
11.8.4 Cipla Inc. Revenue in Imatinib Drugs Business (2019-2024)
11.8.5 Cipla Inc. Recent Development
11.9 Apotex Inc.
11.9.1 Apotex Inc. Company Detail
11.9.2 Apotex Inc. Business Overview
11.9.3 Apotex Inc. Imatinib Drugs Introduction
11.9.4 Apotex Inc. Revenue in Imatinib Drugs Business (2019-2024)
11.9.5 Apotex Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Imatinib Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Capsules
Table 3. Key Players of Tablets
Table 4. Global Imatinib Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Imatinib Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Imatinib Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Imatinib Drugs Market Share by Region (2019-2024)
Table 8. Global Imatinib Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Imatinib Drugs Market Share by Region (2025-2030)
Table 10. Imatinib Drugs Market Trends
Table 11. Imatinib Drugs Market Drivers
Table 12. Imatinib Drugs Market Challenges
Table 13. Imatinib Drugs Market Restraints
Table 14. Global Imatinib Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Imatinib Drugs Market Share by Players (2019-2024)
Table 16. Global Top Imatinib Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Drugs as of 2023)
Table 17. Ranking of Global Top Imatinib Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Imatinib Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Imatinib Drugs Product Solution and Service
Table 21. Date of Enter into Imatinib Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Imatinib Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Imatinib Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Imatinib Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Imatinib Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Imatinib Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Imatinib Drugs Revenue Market Share by Application (2019-2024)
Table 29. Global Imatinib Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Imatinib Drugs Revenue Market Share by Application (2025-2030)
Table 31. North America Imatinib Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Imatinib Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Imatinib Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Imatinib Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Imatinib Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Imatinib Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Imatinib Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Imatinib Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Imatinib Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Imatinib Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Imatinib Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Imatinib Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Imatinib Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Imatinib Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Imatinib Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Teva Company Detail
Table 47. Teva Business Overview
Table 48. Teva Imatinib Drugs Product
Table 49. Teva Revenue in Imatinib Drugs Business (2019-2024) & (US$ Million)
Table 50. Teva Recent Development
Table 51. Viatris Company Detail
Table 52. Viatris Business Overview
Table 53. Viatris Imatinib Drugs Product
Table 54. Viatris Revenue in Imatinib Drugs Business (2019-2024) & (US$ Million)
Table 55. Viatris Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Imatinib Drugs Product
Table 59. Novartis Revenue in Imatinib Drugs Business (2019-2024) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Sanofi S.A. Company Detail
Table 62. Sanofi S.A. Business Overview
Table 63. Sanofi S.A. Imatinib Drugs Product
Table 64. Sanofi S.A. Revenue in Imatinib Drugs Business (2019-2024) & (US$ Million)
Table 65. Sanofi S.A. Recent Development
Table 66. Glenmark Pharmaceuticals Ltd. Company Detail
Table 67. Glenmark Pharmaceuticals Ltd. Business Overview
Table 68. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product
Table 69. Glenmark Pharmaceuticals Ltd. Revenue in Imatinib Drugs Business (2019-2024) & (US$ Million)
Table 70. Glenmark Pharmaceuticals Ltd. Recent Development
Table 71. Sun Pharmaceuticals Company Detail
Table 72. Sun Pharmaceuticals Business Overview
Table 73. Sun Pharmaceuticals Imatinib Drugs Product
Table 74. Sun Pharmaceuticals Revenue in Imatinib Drugs Business (2019-2024) & (US$ Million)
Table 75. Sun Pharmaceuticals Recent Development
Table 76. Dr. Reddy's Laboratories Company Detail
Table 77. Dr. Reddy's Laboratories Business Overview
Table 78. Dr. Reddy's Laboratories Imatinib Drugs Product
Table 79. Dr. Reddy's Laboratories Revenue in Imatinib Drugs Business (2019-2024) & (US$ Million)
Table 80. Dr. Reddy's Laboratories Recent Development
Table 81. Cipla Inc. Company Detail
Table 82. Cipla Inc. Business Overview
Table 83. Cipla Inc. Imatinib Drugs Product
Table 84. Cipla Inc. Revenue in Imatinib Drugs Business (2019-2024) & (US$ Million)
Table 85. Cipla Inc. Recent Development
Table 86. Apotex Inc. Company Detail
Table 87. Apotex Inc. Business Overview
Table 88. Apotex Inc. Imatinib Drugs Product
Table 89. Apotex Inc. Revenue in Imatinib Drugs Business (2019-2024) & (US$ Million)
Table 90. Apotex Inc. Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Imatinib Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Imatinib Drugs Market Share by Type: 2023 VS 2030
Figure 3. Capsules Features
Figure 4. Tablets Features
Figure 5. Global Imatinib Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Imatinib Drugs Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Others Case Studies
Figure 10. Imatinib Drugs Report Years Considered
Figure 11. Global Imatinib Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Imatinib Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Imatinib Drugs Market Share by Region: 2023 VS 2030
Figure 14. Global Imatinib Drugs Market Share by Players in 2023
Figure 15. Global Top Imatinib Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Drugs as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Imatinib Drugs Revenue in 2023
Figure 17. North America Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Imatinib Drugs Market Share by Country (2019-2030)
Figure 19. United States Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Imatinib Drugs Market Share by Country (2019-2030)
Figure 23. Germany Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Imatinib Drugs Market Share by Region (2019-2030)
Figure 31. China Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Imatinib Drugs Market Share by Country (2019-2030)
Figure 39. Mexico Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Imatinib Drugs Market Share by Country (2019-2030)
Figure 43. Turkey Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Imatinib Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Teva Revenue Growth Rate in Imatinib Drugs Business (2019-2024)
Figure 46. Viatris Revenue Growth Rate in Imatinib Drugs Business (2019-2024)
Figure 47. Novartis Revenue Growth Rate in Imatinib Drugs Business (2019-2024)
Figure 48. Sanofi S.A. Revenue Growth Rate in Imatinib Drugs Business (2019-2024)
Figure 49. Glenmark Pharmaceuticals Ltd. Revenue Growth Rate in Imatinib Drugs Business (2019-2024)
Figure 50. Sun Pharmaceuticals Revenue Growth Rate in Imatinib Drugs Business (2019-2024)
Figure 51. Dr. Reddy's Laboratories Revenue Growth Rate in Imatinib Drugs Business (2019-2024)
Figure 52. Cipla Inc. Revenue Growth Rate in Imatinib Drugs Business (2019-2024)
Figure 53. Apotex Inc. Revenue Growth Rate in Imatinib Drugs Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
